Phenotype
|
Fish
|
Conditions
|
Figures
|
pericardium edematous, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2
from Lin et al., 2021
|
whole organism iars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
otolith decreased size, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
eye decreased volume, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
retina layer formation disrupted, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
eye apoptotic process increased occurrence, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
control
|
Fig. 4
from Lin et al., 2021
|
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S8
from Lin et al., 2021
|
brain vacuolated, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
swim bladder uninflated, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2
from Lin et al., 2021
|
inner ear has fewer parts of type inner ear stereocilium, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
inner ear apoptotic process increased occurrence, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
control
|
Fig. 4
from Lin et al., 2021
|
whole organism gnb3b expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
whole organism tulp1b expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism kars1 expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S6
from Lin et al., 2021
|
whole organism tp53 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism qars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism hars expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
brain apoptotic process increased occurrence, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
control
|
Fig. 4
from Lin et al., 2021
|
eye decreased size, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
control
|
Fig. 2 ,
Fig. 4
from Lin et al., 2021
|
motor neuron axon terminus decreased branchiness, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism aimp1b expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism dead, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2
from Lin et al., 2021
|
brain spongy, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism aimp2 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
primary motor neuron axon decreased diameter, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism grk7a expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
whole organism fosab expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S8
from Lin et al., 2021
|
immature anterior macula flattened, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism mbpa expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
thigmotaxis arrested, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
motor neuron neuron projection decreased size, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism casp9 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
whole organism rbp2a expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
otic vesicle decreased size, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2 ,
Fig. 3
from Lin et al., 2021
|
head decreased size, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2
from Lin et al., 2021
|
whole organism neurod2 expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism rars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism lars1b expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
brain segmentation disrupted, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism yars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
trunk apoptotic process increased occurrence, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
control
|
Fig. 4
from Lin et al., 2021
|
retina morphology, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
startle response arrested, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 2
from Lin et al., 2021
|
whole organism neurod1 expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
brain has fewer parts of type neuron, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism eprs1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism stxbp1b expression decreased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
immature posterior macula flattened, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
whole organism mars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism dars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
whole organism casp8 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 4 ,
Fig. S12
from Lin et al., 2021
|
whole organism gars1 expression increased amount, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. S12
from Lin et al., 2021
|
trunk musculature muscle cell morphology, abnormal
|
kars1omf1/omf1 (NHGRI-1)
|
standard conditions
|
Fig. 3
from Lin et al., 2021
|
otolith decreased size, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
pericardium edematous, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
swim bladder uninflated, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
whole organism kars1 expression decreased amount, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S6
from Lin et al., 2021
|
eye decreased size, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
whole organism dead, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
head decreased size, abnormal
|
kars1omf2/omf2 (NHGRI-1)
|
standard conditions
|
Fig. S7
from Lin et al., 2021
|
eye decreased size, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism viability, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
retina layer formation disrupted, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
brain vacuolated, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
brain spongy, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
head decreased size, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
eye decreased volume, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
retina morphology, abnormal
|
NHGRI-1 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
inner ear apoptotic process occurrence, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
eye apoptotic process occurrence, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism gnb3b expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism casp8 expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism casp9 expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
eye size, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism neurod1 expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism mbpa expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
brain apoptotic process occurrence, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
trunk apoptotic process occurrence, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism grk7a expression amount, ameliorated
|
kars1omf1/omf1 + MO4-tp53 (NHGRI-1)
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
head size, ameliorated
|
NHGRI-1 + CRISPR19-tp53 + CRISPR20-tp53 + CRISPR21-tp53 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
whole organism viability, ameliorated
|
NHGRI-1 + CRISPR19-tp53 + CRISPR20-tp53 + CRISPR21-tp53 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
brain structure, ameliorated
|
NHGRI-1 + CRISPR19-tp53 + CRISPR20-tp53 + CRISPR21-tp53 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
retina morphology, ameliorated
|
NHGRI-1 + CRISPR19-tp53 + CRISPR20-tp53 + CRISPR21-tp53 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|
eye size, ameliorated
|
NHGRI-1 + CRISPR19-tp53 + CRISPR20-tp53 + CRISPR21-tp53 + CRISPR3-kars1 + CRISPR4-kars1 + CRISPR5-kars1 + CRISPR6-kars1 + CRISPR7-kars1
|
standard conditions
|
Fig. 4
from Lin et al., 2021
|